Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

SIMCERE PHARMA(02096.HK)

Event Tracking

Mar30

08:46

Xiansheng Pharmaceutical Expected to See Significant Growth in Revenue and Net Profit in 2026

08:07

Mar25

Simcere Acquires Shanghai Simcere Diagnosis Technology Equity

15:14

Simcere Pharmaceutical Announces Significant Revenue and Profit Growth in 2025

15:09

SIMCERE PHARMA released FY2025 9 Months Earnings on March 25, 2026 (BJT), with actual revenue of HKD 6.148 B and EPS of HKD 0.4255

15:00

SIMCERE PHARMA released FY2025 Q3 earnings on March 25, 2026 (BJT) with actual revenue of HKD 2.266 B and EPS of HKD 0.1581

15:00

Schedules & Filings

Schedules

Filings

Jun17

Distribution Plan(CST)

Cash dividend 0.2043 HKD

Mar25

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 2.306 B, Net Income 411.67 M, EPS 0.1608

SIMCERE PHARMA (2096.HK) 2025 Annual Performance Release Conference

Distribution Plan(CST)

Cash dividend 0.2043 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

SIMCERE PHARMA(02096.HK)

SIMCERE PHARMA Stock Performance Chart